Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
Missouri Farm Bureau President Garrett Hawkins discusses the potential impact of data center growth on farmland, the Landowner Fairness Act, and key priorities for Missouri farmers heading into planting season.
A man accused of orchestrating a nationwide cattle investment fraud scheme has been arrested in California after being on the FBI’s wanted list.
ASFMRA’s Craig Thompson shares insights for American farmers who are navigating farmland markets amid agricultural uncertainty.
OHFB President Bill Patterson shares an update from Washington on the group’s policy priorities and the issues shaping agriculture ahead of the 2026 planting season.
Ben Kurtzman with American Farmland Trust discusses the growing pressure on farmland and ranchland and the steps being taken to help conserve farms and ranches across the country ,as unrest in the Middle East adds more obstacles for producers.
Former U.S. Secretary of Agriculture and Kansas congressman Dan Glickman joined RFD News to share his outlook on agricultural policy, bipartisan cooperation, and the challenges facing farmers today.
